Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges

Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder, is typified by both motor and nonmotor symptoms. The current medications provide symptomatic relief but do not stimulate the production of new dopaminergic neurons in the substantia nigra. Astrocyte reprogramming has rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhuang-Yao D., Shetty, Ashok K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221613/
https://www.ncbi.nlm.nih.gov/pubmed/34162545
http://dx.doi.org/10.1126/sciadv.abg3198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221613/
https://www.ncbi.nlm.nih.gov/pubmed/34162545
http://dx.doi.org/10.1126/sciadv.abg3198

Ejemplares similares